local_hospital

Ambulatory For Individual Practice For Primary Medical Aid AIPPMP Dr. Zhaneta Demireva EOOD

Address
2 Antim I Street 2nd Floor Cabinets 1 2 3 And 4, 4210 Stamboliyski, Bulgaria

Cardiovascular Diseases

At Ambulatory For Individual Practice For Primary Medical Aid AIPPMP Dr. Zhaneta Demireva EOOD in Stamboliyski, clinical research in cardiovascular medicine focuses on people with established atherosclerotic cardiovascular disease (ASCVD). The studies are designed to assess whether new treatment approaches can better reduce major heart and stroke-related risks compared with existing care.

  • Reducing the risk of cardiovascular death, heart attack, and ischemic stroke
  • Evaluating a new therapy for patients with established vascular disease

This work supports efforts to improve treatment effectiveness for high-risk patients living with advanced cardiovascular disease.

Virus Diseases

The site also contributes to research in viral infections, with a focus on influenza in adults. These trials aim to determine the safety, immune response, and overall protective value of a new vaccine candidate compared with a licensed influenza vaccine.

  • Testing a vaccine candidate against seasonal influenza
  • Assessing safety, reactogenicity, and immune protection

By studying influenza A and B prevention, the research helps advance better vaccination strategies for older adults and other at-risk groups.

Site Overview

assignment
3
connected trials
corporate_fare
3
sponsors
science
12
IMPs

Activity Indicator

Last 6 months

0
Trials started
0
Trials started 6–12 months ago
3
Total trials linked
Moderately Active
trending_flatStable0%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
0
Sponsors (total)
3
Active sponsors
0

Sponsor Network

Top 10 by active trials.

No sponsors linked to active trials.

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

No repeated partnerships found.

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 476 other sites in Bulgaria

description
Trial volume
3
Outperforms 46% of sites
public
Therapeutic diversity
2areas
Outperforms 47% of sites
groups
Sponsor diversity
3sponsors
Outperforms 53% of sites

Therapeutic Area Benchmark — Bulgaria

Select a therapeutic area to compare against other sites in Bulgaria.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Bulgaria

Market Share

Country: Bulgaria

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Ambulatory For Individual Practice For Primary Medical Aid AIPPMP Dr. Zhaneta Demireva EOOD

lock Showing 1 of 3 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
Efficacy and Safety Evaluation of MF59-Adjuvanted Influenza Vaccine Versus Non-Adjuvanted Vaccine in Adults Aged 65 and OlderSeqirus UK LimitedPhase IIINot RecruitingOct 2023

IMP list

lock Showing 1 of 12 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
A/Victoria/4897/2022 (H1N1)Pdm09-Like Strain (A/Victoria/4897/2022, Ivr-238)2Unknown2023-10-202024-10-11

Request feasibility information

Ask this centre about capacity, equipment and patient population.

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.